Proniras
Business Services · Washington, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2815 Eastlake Ave E Ste 300, Seattle, Wa...Phone Number
(206) 957-7300Website
www.proniras.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Proniras
Proniras Corporation is a Seattle-based biotechnology company focused on developing tezampanel as a potential treatment for opioid withdrawal and related disorders of addiction. Although effective treatments exist for opioid addiction, painful and difficult withdrawal is one of the reasons treatment fails, and relapse occurs. By alleviating symptoms associated with opioid withdrawal, Proniras hopes to help patients complete their discontinuation of opioids and facilitate successful treatment. The development of tezampanel for opioid withdrawal is supported by federal funding from the National Institute on Drug Abuse (NIDA), under Grant No. 1UG3DA050923-01. Proniras was founded in 2017 by Accelerator Life Science Partners and Christopher Toombs, PhD, DABT.Explore more
Proniras Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Proniras your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Proniras had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Proniras has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Proniras
Proniras, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Proniras has recently received funding, and reach out quickly before it becomes old news!
Check out if Proniras is spiking on competitors!
Product Launch: Get notified when Proniras launches new products
Earning: See what the market has to say on Proniras recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Proniras
Find 2 more new buyers
Compare Similar Companies to Proniras
Compare insights from companies similar to Proniras, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Proniras is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Proniras is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Proniras.
Proniras financials insights
Gather financial insights about Proniras, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series B
$4.7M
Proniras Tech Stack
A closer look at the technologies used by Proniras
See more technologies
Most Recent Scoops
Funding
Executive Move
Board of Directors
Executive Move
Board of Directors
Executive Move
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Proniras
Sign Up For FreeTo access detailed company insights
Proniras Corporation is a Seattle-based biotechnology company focused on developing tezampanel as a potential treatment for opioid withdrawal and related disorders of addiction. Although effective treatments exist for opioid addiction, painful and difficult withdrawal is one of the reasons treatment fails, and relapse occurs. By alleviating symptom... Read More
